Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry

Georgina L. Ryland; Kate Jones; Michelle McBean; Amit Khot; John F. Seymour; Piers Blombery

doi:10.1080/10428194.2017.1361029

Shared by

Amit Khot

University of Melbourne

Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry

Letter 2017 en

Authors

GR
Georgina L. Ryland
KJ
Kate Jones
MM
Michelle McBean

Abstract

1 min read

Burkitt lymphoma (BL) is a germinal center B-cell-derived malignancy characterized by oncogenic MYC activation through translocation with one of the immunoglobulin loci. This highly aggressive lymp...

Related publications

Article2020

Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells

Emilia Białopiotrowicz, Monika Noyszewska‐Kania, Neli Kachamakova‐Trojanowska, Agnieszka Łoboda, Magdalena Cybulska, Aleksandra Grochowska, Michał Kopczyński, Michał Mikuła, Monika Prochorec‐Sobieszek, Małgorzata Firczuk, Agnieszka Graczyk‐Jarzynka, Radosław Zagożdżon, Adam Ząbek, Piotr Młynarz, Jozef Dulak, Patryk Górniak, Maciej Szydłowski, Karolina Pyziak, Justyna Martyka, Agnieszka Sroka‐Porada, Ewa Jabłońska, Anna Polak, Piotr Kowalczyk, Anna Szumera‐Ciećkiewicz, Bjoern Chapuy, Tomasz Rzymski, Krzysztof Brzózka, Przemysław Juszczyński

Article2023

IMMUNOGLOBULIN CLASS DICTATES TRANSFORMATION TRAJECTORY AND BCR STATUS OF MYC/BCL2 DOUBLE‐HIT LYMPHOMA: BIOLOGY AND CLINICAL IMPLICATIONS

Stefano Casola, Paola Sindaco, Silvia Lonardi, Franca Zanardi, Hadar Neuman, Luisa Lorenzi, Piera Balzarini, G. Morello, Gabriele Varano, Mattia Bugatti, M. Chairini, G. Bertolazzi, Hiroshi Arima, Cecilia Ranise, Sabrina Giampaolo, Daniel Garzon, Pasquale Capaccio, Federica Mainoldi, Rosa Daffini, Silvia Zini, V. Péllegrini, Sabrina Manni, ,

Article2010

Burkitt’s Lymphoma in Pregnancy with Bilateral Breast Involvement: Case Report with Review of the Literature

Paraskevi Savvari, Chara Matsouka, Despoina Barbaroussi, Dimitrios Christoulas, Nikitas Nikitas, Meletios A Dimopoulos, Christos Papadimitriou

Article2025

Stepwise engineering of human germinal center B cells to model dark zone high-grade B cell lymphoma driven by sequential BCL2 and MYC deregulation

Sabrina Giampaolo, Elena Morlacchi, Federica Mainoldi, Maryam Mohammadi, Dafne Barozzi, Adriana Palmeri, Silvia Lonardi, Giovanni Lembo, Giada Cicio, Federica Pisati, Pasquale Capaccio, Sara Torretta, Lorenzo Pignataro, Luisa Lorenzi, Francesco Ferrari, Claudio Tripodo, Cristina Scielzo, Daniel J. Hodson, Gabriele Varano, Stefano Casola

Article2015

The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma

Bruna Barneda‐Zahonero, Olga Collazo, Alba Azagra, Irene Fernández-Duran, Jordi Serra-Musach, Abul Bashar Mir Md. Khademul Islam, Nerea Vega‐García, Roberta Malatesta, Mireia Cámos, Antonio Gómez, Lidia Román-González, August Vidal, Núria López-Bigas, Alberto Villanueva, Manel Esteller, Maribel Parra

Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry

Abstract

Discussion(0)

Related publications

Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells

IMMUNOGLOBULIN CLASS DICTATES TRANSFORMATION TRAJECTORY AND BCR STATUS OF MYC/BCL2 DOUBLE‐HIT LYMPHOMA: BIOLOGY AND CLINICAL IMPLICATIONS

Burkitt’s Lymphoma in Pregnancy with Bilateral Breast Involvement: Case Report with Review of the Literature

Stepwise engineering of human germinal center B cells to model dark zone high-grade B cell lymphoma driven by sequential BCL2 and MYC deregulation

The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma